Taxotere (Docetaxel (XT) Anti-mitotic Chemotherapy Medication and Permanent Hair Loss

Video Transcript: Hundreds-of-thousands of women are diagnosed with breast cancer every year. Some of these women may suffer permanent hair loss as a side effect of their chemotherapy treatments. Hello, I’m attorney Rosemarie Bogdan, and if you’re one of those women there’s a good chance you may have been treated with Taxotere, one of the most widely used breast cancer drugs in its class. Taxotere was cleared by the FDA to treat breast cancer along with a variety of other cancers, including head and neck cancer, advanced stomach cancer and metastatic prostate cancer. Although temporary hair loss is a fairly common side effect of chemotherapy treatment, permanent hair loss – or permanent alopecia – is not. A 2013 study published by the National Cancer Research Institute found that permanent hair loss occurred in 10-15% of all patients who took Taxotere. More than 10 years ago, the European Union required the manufacturer to place a warning of persistent hair loss on the product label. However, the manufacturer failed to place this warning on the product here in the U.S. until the FDA mandated a label warning in December of 2015. Lawsuits are being filed around the country claiming the manufacturer failed to warn patients and physicians about the risk of permanent hair loss associated with Taxotere. If you’ve suffered permanent hair loss after undergoing chemotherapy treatment for cancer you may be entitled to a compensable claim. Visit http://1800law1010.com/defective-drug... to chat 24/7 or call us now at 1800LAW1010 for a free, no obligation case evaluation.